Cargando…
A cell-autonomous tumour suppressor role of RAF1 in hepatocarcinogenesis
Hepatocellular carcinoma (HCC) is a leading cause of cancer deaths, but its molecular heterogeneity hampers the design of targeted therapies. Currently, the only therapeutic option for advanced HCC is Sorafenib, an inhibitor whose targets include RAF. Unexpectedly, RAF1 expression is reduced in huma...
Autores principales: | Jeric, Ines, Maurer, Gabriele, Cavallo, Anna Lina, Raguz, Josipa, Desideri, Enrico, Tarkowski, Bartosz, Parrini, Matthias, Fischer, Irmgard, Zatloukal, Kurt, Baccarini, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187498/ https://www.ncbi.nlm.nih.gov/pubmed/28000790 http://dx.doi.org/10.1038/ncomms13781 |
Ejemplares similares
-
Epidermal RAF prevents allergic skin disease
por: Raguz, Josipa, et al.
Publicado: (2016) -
“RAF” neighborhood: Protein–protein interaction in the Raf/Mek/Erk pathway
por: Cseh, Botond, et al.
Publicado: (2014) -
Ras and Raf pathways in epidermis development and carcinogenesis
por: Kern, F, et al.
Publicado: (2011) -
Ras and Raf pathways in epidermis development and carcinogenesis
por: Kern, F, et al.
Publicado: (2011) -
Raf-1 sets the threshold of Fas sensitivity by modulating Rok-α signaling
por: Piazzolla, Daniela, et al.
Publicado: (2005)